SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001214659-20-007189
Filing Date
2020-08-14
Accepted
2020-08-14 16:16:28
Documents
48
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 h81020310q.htm 10-Q 469062
2 EXHIBIT 31.1 ex31_1.htm EX-31.1 8408
3 EXHIBIT 31.2 ex31_2.htm EX-31.2 8475
4 EXHIBIT 32.1 ex32_1.htm EX-32.1 4394
5 EXHIBIT 32.2 ex32_2.htm EX-32.2 4519
6 GRAPHIC chart.jpg GRAPHIC 185115
  Complete submission text file 0001214659-20-007189.txt   2855353

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE hgen-20200630.xml EX-101.INS 316111
8 XBRL SCHEMA FILE hgen-20200630.xsd EX-101.SCH 44572
9 XBRL CALCULATION FILE hgen-20200630_cal.xml EX-101.CAL 31513
10 XBRL DEFINITION FILE hgen-20200630_def.xml EX-101.DEF 135766
11 XBRL LABEL FILE hgen-20200630_lab.xml EX-101.LAB 299116
12 XBRL PRESENTATION FILE hgen-20200630_pre.xml EX-101.PRE 196280
Mailing Address 533 AIRPORT BLVD. SUITE 400 BURLINGAME CA 94010
Business Address 533 AIRPORT BLVD. SUITE 400 BURLINGAME CA 94010 650.243.3100
HUMANIGEN, INC (Filer) CIK: 0001293310 (see all company filings)

IRS No.: 770557236 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35798 | Film No.: 201105285
SIC: 2834 Pharmaceutical Preparations